Related Experiment Video

Updated: Apr 5, 2026

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses
11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

17.6K

The changing landscape of respiratory syncytial virus

Fernando P Polack1

  • 1Vanderbilt Vaccine Center at Vanderbilt University, Nashville, TN, United States; Fundacion INFANT, Buenos Aires, Argentina.

Vaccine
|August 7, 2015
PubMed

Insights

Respiratory syncytial virus (RSV) causes significant infant hospitalizations and childhood asthma. New preventive strategies may alter RSV

Area of Science:

  • Pediatric infectious diseases
  • Virology
  • Public health

Background:

  • Respiratory syncytial virus (RSV) poses a major global health burden, particularly for infants.
  • RSV is a leading cause of lower respiratory tract infections (LRTI), hospitalization, and mortality in infants.
  • RSV infection is linked to recurrent wheezing and pediatric asthma development.

Purpose of the Study:

  • To outline potential epidemiological and clinical changes in RSV LRTI.
  • To discuss future scenarios for RSV management with novel interventions.
  • To review current literature and experiences with other pathogens.

Main Methods:

  • Literature review and synthesis.
  • Epidemiological data analysis (implied).
  • Scenario modeling based on existing data.

Main Results:

  • Anticipated shifts in RSV LRTI epidemiology.
  • Potential changes in clinical presentation and severity.
  • Impact of novel preventive strategies on disease burden.

Conclusions:

  • Novel preventive strategies for RSV are expected to significantly impact LRTI outcomes.
  • Understanding these potential changes is crucial for public health planning.
  • Future management of RSV will likely involve a combination of interventions.

Keywords:
Enhanced respiratory syncytial virus diseaseInfant mortalityPregnancyRecurrent wheezingRespiratory syncytial virusVaccines

More Related Videos

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection09:01

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

8.5K
An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay09:14

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

Published on: January 26, 2019

11.7K

Related Concept Videos

Common Respiratory Disorders01:31

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
1.8K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
4.2K
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more...
37
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.6K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

6.0K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.5K